A Phase I Clinical Trial to Compare the Pharmacokinetics, Safety and Immunogenicity of SJ04 and Ovidrel in Healthy Female Subjects in China
Latest Information Update: 30 Sep 2024
Price :
$35 *
At a glance
- Drugs SJ 04 (Primary) ; Choriogonadotropin alfa
- Indications Infertility
- Focus Pharmacokinetics
- Sponsors Shanghai Bao Pharmaceuticals
- 30 Sep 2024 New trial record